In immunohistochemical analysis, we found that LIMK2 expression was significantly higher in breast cancer samples, including those of TNBC, than in normal tissue (Fig. S1a, b, Table S1, Figs. 1a, b, and S1c). Here, LIMK2 is linked to breast cancer.